Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-14

Clinical Trial Update: Association of Capecitabine Pharmacokinetics and Toxicity With Aging [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating whether aging influences capecitabine pharmacokinetics and related toxicity in patients with breast or colorectal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xeloda (capecitabine)

Snippet

Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust | Conditions: Breast Cancer, Colorectal Cancer | Phase 4 | Status: UNKNOWN